Skip to content
★ Sign in to follow
Brainsway Ltd. logo

Brainsway Ltd. Stock: price and insider trades · United States

US·Mcap US$463.3M

Brainsway Ltd.: what insiders have been doing

Brainsway Ltd., founded in 2003, is a listed company based in Jerusalem, Israel. Its directors and officers file their transactions with SEC (Form 4). The last twelve months, up to 8 November 2026, brought 13 filings signed by 3 insiders.

The flow runs one way only: 7 sales, from 3 insiders, and no purchase. The totals exclude 7 filings filed without an amount.

Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.

With 13 filings in twelve months, the company is quieter than the median of 19 filings across the 5,808 companies we follow on the same exchange. Looking back to 2026, when coverage begins, insiders filed no purchases and 7 sales.

For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
13
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
7 ops. · all time

Who traded when

BuySale
Yiftach Roth4 sales
Rayten Michal Ety Mitrany2 sales
Gilad Moiseyev1 sale
Fundamental score
Ranked 10,519 of 26,897 companies
57.0
score / 100
Value
35
Quality
79
FCF yld3.5%
Earn yld1.7%
EV/EBITDA40.8x
ROE13%
Gross mgn75%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$11.51
Analyst consensus
3 analysts
·
US$18.80Target US$19.27(+67%)US$20.00
Income statement
RevenueUS$52.2M
Gross profitUS$39.4M75% margin
EBITDAUS$11.5M22% margin
Net incomeUS$7.6M15.6% margin
Valuation
PER (trailing)50.0x
PER (forward)22.7x
P/Book5.8x
Beta0.10
Balance sheet & cash
Market capUS$463.3M
Total debtUS$6.8M
Free Cash FlowUS$16.3M
Debt / Equity9%
Profitability & ownership
ROE12.8%
ROA4.0%
% insiders2.6%
% institutions29.6%
Last declaration on 22 June 2026
Declarations13 total
  • ◇
    Chief Technology OfficerExecutives
    0SEC
    7,500 sharesOrdinary SharesSEC:0001171843-26-004216:0
  • ◆
    Chief Technology OfficerExecutives
    0SEC
    1,902 sharesOrdinary SharesSEC:0001171843-26-004216:1
  • ▼
    Chief Technology OfficerExecutives
    0SEC
    5,000 sharesOrdinary SharesSEC:0001171843-26-004216:2
  • ▼
    Chief ScientistExecutives
    0SEC
    2,000 sharesOrdinary SharesSEC:0001171843-26-003899:0
  • ▼
    Chief ScientistExecutives
    0SEC
    2,000 sharesOrdinary SharesSEC:0001171843-26-003899:1
  • ▼
    Chief ScientistExecutives
    0SEC
    1,000 sharesOrdinary SharesSEC:0001171843-26-003899:2
  • ▼
    Chief ScientistExecutives
    0SEC
    2,000 sharesOrdinary SharesSEC:0001171843-26-003899:3
  • ▼
    DirectorExecutives
    0SEC
    10,000 sharesOrdinary SharesSEC:0001171843-26-003696:0
  • ▼
    DirectorExecutives
    0SEC
    7,980 sharesOrdinary SharesSEC:0001171843-26-003696:1
  • ◇
    DirectorExecutives
    0SEC
    10,000 sharesOrdinary SharesSEC:0001171843-26-003596:0
  • ◆
    DirectorExecutives
    0SEC
    3,440 sharesOrdinary SharesSEC:0001171843-26-003596:1
  • ◇
    DirectorExecutives
    0SEC
    17,500 sharesOrdinary SharesSEC:0001171843-26-003596:2
  • ◆
    DirectorExecutives
    0SEC
    6,080 sharesOrdinary SharesSEC:0001171843-26-003596:3

13 of 13 declarations

About Brainsway Ltd.

Brainsway Ltd. is a company focused on developing non-invasive treatments for neurological disorders using transcranial magnetic stimulation. It is listed on NASDAQ under the ticker BWAY.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations